CVS Health Price to Sales

CVS -- USA Stock  

USD 67.90  0.04  0.06%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Price to Sales Analysis

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
CVS Health 
P/S 
 = 
MV Per Share 
Revenue Per Share 
 = 
0.38 times

Price to Sales Over Time Pattern

 CVS Health Price to Sales Ratio 
      Timeline 

About Price to Sales

The most important factor to remember is that the price of equity takes a firm's debt into account, whereas the sales does not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Compare to competition

CVS Health Price to Sales Assessment

Sales

CVS Health Sales Growth Over Time

Price to Sales Ratio

Return on Sales

Based on latest financial disclosure the price to sales indicator of CVS Health Corporation is roughly 0.38 times. This is 98.22% lower than that of the Healthcare sector, and significantly higher than that of Healthcare Services industry, The Price to Sales for all stocks is 97.87% higher than the company.

Peer Comparison

CVS Health Price to Sales Comparison
CVS Health is rated fourth in price to sales category among related companies.

Current CVS Health financial ratios

Return On Equity18.39 %
Return On Asset5.55 %
Profit Margin3.59 %
Operating Margin6.79 %
Current Valuation91.92 B
Shares Outstanding1.02 B
Shares Owned by Insiders0.26 %
Shares Owned by Institutions85.69 %
Number of Shares Shorted43.66 M
Price to Earning10.52 times
Price to Book1.80 times
Price to Sales0.38 times
Revenue185.94 B
Gross Profit28.55 B
EBITDA12.62 B
Net Income6.65 B
Cash and Equivalents42.14 B
Cash per Share41.45 times
Total Debt65.09 B
Debt to Equity168.30 %
Current Ratio2.37 times
Book Value Per Share38.06 times
Cash Flow from Operations5.05 B
Short Ratio5.81 times
Earnings Per Share6.52 times
Price to Earnings To Growth0.85 times
Number of Employees160 K
Beta0.9
Market Capitalization69.77 B
Total Asset93.66 B
Retained Earnings38.98 B
Working Capital7.21 B
Current Asset30.38 B
Current Liabilities23.17 B
Z Score1.6
Five Year Return1.79 %
Last Dividend Paid2.0